Mbodies Pilates Instructor Training Academy

  The 2023 American Society for Clinical Oncology (ASCO) annual clinical meeting in cancer research showcased groundbreaking advances in Breast Cancer treatment. Among the plethora of clinical trial updates, two stand out as game-changers. Firstly, CDK4/6 inhibitors are taking a prominent position in Breast Cancer therapy.  Cyclin-dependent kinase 4 and 6 (CDK4 and CDK6) are enzymes important in cell division.  CDK4/6 inhibitors are drugs designed to interrupt the growth of cancer cells.  CDK4/6 inhibitors are used in combination with hormone therapy to treat some Breast Cancers.  These inhibitors block cancer cells' growth cycle, preventing cancer progression, and were initially developed as a treatment option for endocrine therapy-resistant Breast Cancer.  Palbociclib (Ibrance®) received American FDA approval in 2015, followed by ribociclib (Kisqali®) and abemaciclib (Verzenio®) in 2017 and in the UK NICE approved it in 2018.  Researchers presented trials with these inhibitors

  What is Good for the Heart is Good for the Brain: A Pilates Perspective With wellness and brain health gaining prominence, individuals are increasingly focused on optimising cognitive function and preventing neurological disorders. As the understanding of brain health evolves, it becomes clear that it is a critical aspect of overall well-being, intertwined with mental health and physical wellness. The brain is a complex organ that impacts every aspect of life, from mood and memory to more serious neurological conditions. However, the definition of brain health remains broad and lacks universal acceptance. While some may confuse brain health with mental health, they are distinct but related concepts, as recognised by the World Health Organisation. The growing interest in brain care is evident, with the global neuroscience market projected to exceed £ 565 billion by 2026. Brain health disorders account for a staggering £2.35 trillion of lost productivity annually. Research on bra